• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英夫利昔单抗治疗眼内炎症时的皮肤不良反应。

Adverse skin reactions to infliximab in the treatment of intraocular inflammation.

作者信息

Wegscheider B J, El-Shabrawi L, Weger M, Ardjomand N, Hermann J, Aberer E, El-Shabrawi Y

机构信息

Department of Ophthalmology, Medical University of Graz, Graz, Austria.

出版信息

Eye (Lond). 2007 Apr;21(4):547-9. doi: 10.1038/sj.eye.6702262. Epub 2006 Feb 3.

DOI:10.1038/sj.eye.6702262
PMID:16456589
Abstract

TNFalpha inhibitors are more widely used in the treatment of intraocular inflammation, thus ophthalmologists should become aware of possible adverse events, associated with this form of treatment. Herein we report two cases of cutaneous adverse events in uveitis patients treated with infliximab. In one patient, the primary outbreak of pustular psoriasis was observed after her third infusion. A second patient developed impetigo contagiosa induced by Staphylococcus aureus. Thus patients undergoing treatment with infliximab should be monitored carefully since dermal infections and pustular psoriasis, which may be triggered by streptococcal infection, may occur under this regime.

摘要

肿瘤坏死因子α抑制剂在眼内炎症治疗中的应用更为广泛,因此眼科医生应了解这种治疗方式可能伴随的不良事件。在此,我们报告两例使用英夫利昔单抗治疗的葡萄膜炎患者发生皮肤不良事件的病例。其中一名患者在第三次输注后出现脓疱型银屑病初发。另一名患者发生了由金黄色葡萄球菌引起的脓疱疮。因此,接受英夫利昔单抗治疗的患者应接受仔细监测,因为在这种治疗方案下可能会发生由链球菌感染引发的皮肤感染和脓疱型银屑病。

相似文献

1
Adverse skin reactions to infliximab in the treatment of intraocular inflammation.英夫利昔单抗治疗眼内炎症时的皮肤不良反应。
Eye (Lond). 2007 Apr;21(4):547-9. doi: 10.1038/sj.eye.6702262. Epub 2006 Feb 3.
2
Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.依那西普和英夫利昔单抗治疗眼部炎症的疗效差异
Ophthalmology. 2006 Dec;113(12):2317-23. doi: 10.1016/j.ophtha.2006.04.038. Epub 2006 Sep 25.
3
Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.英夫利昔单抗治疗重度、难治性银屑病:一项前瞻性、开放标签研究。
Br J Dermatol. 2006 Jul;155(1):160-9. doi: 10.1111/j.1365-2133.2006.07316.x.
4
Psoriasiform and pustular eruption induced by infliximab.英夫利昔单抗诱发的银屑病样和脓疱性皮疹。
J Dermatol. 2007 Jul;34(7):468-72. doi: 10.1111/j.1346-8138.2007.00312.x.
5
Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-α inhibitor therapy. A study of 16 biopsies.与肿瘤坏死因子-α抑制剂治疗相关的银屑病样皮肤反应的组织病理学谱。16例活检病例的研究。
Am J Dermatopathol. 2010 Aug;32(6):568-73. doi: 10.1097/DAD.0b013e3181cb3ff7.
6
Predictive factors of eczema-like eruptions among patients without cutaneous psoriasis receiving infliximab: a cohort study of 92 patients.接受英夫利昔单抗治疗的非皮肤性银屑病患者中出现湿疹样皮疹的预测因素:一项 92 例患者的队列研究。
Dermatology. 2009;219(3):263-7. doi: 10.1159/000235582. Epub 2009 Aug 13.
7
Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.肿瘤坏死因子-α拮抗剂治疗诱发的银屑病:病例系列
J Rheumatol. 2007 Feb;34(2):380-5. Epub 2006 Oct 1.
8
[Infectious risk].[感染风险]
Actas Dermosifiliogr. 2008 Jul;99 Suppl 4:14-22.
9
A case of infliximab-induced psoriasis.1例英夫利昔单抗诱发的银屑病。
Dermatol Online J. 2008 Nov 15;14(11):9.
10
[Indications and adverse events with the use of anti-TNFalpha agents in pediatric rheumatology: experience of a single center].[抗TNFα药物在儿童风湿病中的应用指征及不良事件:单中心经验]
Acta Reumatol Port. 2007 Apr-Jun;32(2):139-50.

引用本文的文献

1
Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center.全球使用乌司奴单抗、司库奇尤单抗和肿瘤坏死因子-α抑制剂的细菌皮肤感染和疱疹病毒感染风险:世界卫生组织药物警戒中心不良药物反应自发报告。
Acta Derm Venereol. 2022 Feb 11;102:adv00648. doi: 10.2340/actadv.v102.175.
2
Tumor necrosis factor-α inhibitor-induced psoriasis: Systematic review of clinical features, histopathological findings, and management experience.肿瘤坏死因子-α抑制剂诱发的银屑病:临床特征、组织病理学表现及治疗经验的系统评价
J Am Acad Dermatol. 2017 Feb;76(2):334-341. doi: 10.1016/j.jaad.2016.08.012. Epub 2016 Oct 5.
3
Case series in drug safety: a review to determine characteristics and quality.药物安全的病例系列:一项评估特征和质量的综述。
Drug Saf. 2010 Dec 1;33(12):1081-8. doi: 10.2165/11539300-000000000-00000.
4
The changing face of spondyloarthropathies under TNF α blockade.肿瘤坏死因子α阻断治疗下脊柱关节炎的变化面貌。
Open Rheumatol J. 2008;2:53-7. doi: 10.2174/1874312900802010053. Epub 2008 Nov 14.
5
Intravitreal administration of the anti-TNF monoclonal antibody infliximab in the rabbit.在兔体内玻璃体内注射抗TNF单克隆抗体英夫利昔单抗。
Graefes Arch Clin Exp Ophthalmol. 2009 Feb;247(2):273-81. doi: 10.1007/s00417-008-0967-4. Epub 2008 Nov 4.
6
Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: report on five cases.英夫利昔单抗治疗斑块型银屑病期间或之后掌跖脓疱病的表现:5例报告
Arch Dermatol Res. 2008 Mar;300(3):101-5. doi: 10.1007/s00403-008-0831-8. Epub 2008 Feb 1.